Nicolau DP - Search Results

1

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.

Lacy MK, Lu W, Xu X, Tessier PR, Nicolau DP, Quintiliani R, Nightingale CH. Lacy MK, et al. Among authors: nicolau dp. Antimicrob Agents Chemother. 1999 Mar;43(3):672-7. doi: 10.1128/AAC.43.3.672. Antimicrob Agents Chemother. 1999. PMID: 10049286 Free PMC article.

2

Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.

Kuti JL, Nightingale CH, Quintiliani R, Nicolau D. Kuti JL, et al. Diagn Microbiol Infect Dis. 2002 Sep;44(1):51-7. doi: 10.1016/s0732-8893(02)00416-9. Diagn Microbiol Infect Dis. 2002. PMID: 12376031

3

Ofloxacin vs ciprofloxacin: a comparison.

Nicolau D, Quintiliani R, Nightingale CH. Nicolau D, et al. Conn Med. 1992 May;56(5):261-3. Conn Med. 1992. PMID: 1611900 Review.

4

Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy.

Santos Filho L, Eagye KJ, Kuti JL, Nicolau DP. Santos Filho L, et al. Among authors: nicolau dp. Clin Microbiol Infect. 2007 Jun;13(6):579-85. doi: 10.1111/j.1469-0691.2007.01693.x. Epub 2007 Feb 28. Clin Microbiol Infect. 2007. PMID: 17331121 Free article.

5

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.

Nicolau DP, McNabb J, Lacy MK, Quintiliani R, Nightingale CH. Nicolau DP, et al. Int J Antimicrob Agents. 2001 Jun;17(6):497-504. doi: 10.1016/s0924-8579(01)00329-6. Int J Antimicrob Agents. 2001. PMID: 11397621 Clinical Trial.

6

Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.

Owens RC Jr, Tessier P, Nightingale CH, Ambrose PG, Quintiliani R, Nicolau DP. Owens RC Jr, et al. Among authors: nicolau dp. Int J Antimicrob Agents. 2001 Jun;17(6):483-9. doi: 10.1016/s0924-8579(01)00322-3. Int J Antimicrob Agents. 2001. PMID: 11397619 Clinical Trial.

7

Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa.

McNabb J, Quintiliani R, Nightingale CH, Nicolau DP. McNabb J, et al. Among authors: nicolau dp. Chemotherapy. 2000 Nov-Dec;46(6):383-9. doi: 10.1159/000007318. Chemotherapy. 2000. PMID: 11053903 Clinical Trial.

8

Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci.

Lacy MK, Tessier PR, Nicolau DP, Nightingale CH, Quintiliani R. Lacy MK, et al. Among authors: nicolau dp. Int J Antimicrob Agents. 2000 Jun;15(1):25-30. doi: 10.1016/s0924-8579(00)00121-7. Int J Antimicrob Agents. 2000. PMID: 10856673 Clinical Trial.

9

In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.

Bui KQ, Banevicius MA, Nightingale CH, Quintiliani R, Nicolau DP. Bui KQ, et al. Among authors: nicolau dp. J Antimicrob Chemother. 2000 Jan;45(1):57-62. doi: 10.1093/jac/45.1.57. J Antimicrob Chemother. 2000. PMID: 10629013

10

Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.

Lacy MK, Nicolau DP, Banevicius MA, Nightingale CH, Quintiliani R. Lacy MK, et al. Among authors: nicolau dp. J Antimicrob Chemother. 1999 Oct;44(4):477-81. doi: 10.1093/jac/44.4.477. J Antimicrob Chemother. 1999. PMID: 10588309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results